跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GRINTEROL HARD CAPSULE 250MG - HSA Drug Approval Details
Approvals
/
HSA
/
GRINTEROL HARD CAPSULE 250MG
Approved
THERAPEUTIC
GRINTEROL HARD CAPSULE 250MG
JOINT STOCK COMPANY “GRINDEKS” (LATVIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 12, 2020
Approval ID
8085e5ba30f800e0
Company
JOINT STOCK COMPANY “GRINDEKS” (LATVIA)
Type
Therapeutic
Approval Details
Approval Id
8085e5ba30f800e0
Drug Name
GRINTEROL HARD CAPSULE 250MG
Product Name
GRINTEROL HARD CAPSULE 250MG
Approval Number
SIN15883P
Approval Date
2020-02-12
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
A05AA02
Atc Item Name
ursodeoxycholic acid
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
URSODEOXYCHOLIC ACID
250MG
URSODEOXYCHOLIC ACID
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 12, 2020
Approval ID
8085e5ba30f800e0
Type
Therapeutic
Back to HSA Approvals